114 related articles for article (PubMed ID: 11042673)
1. CD40 ligand, Bcl-2, and Bcl-xL spare group I Burkitt lymphoma cells from CD77-directed killing via Verotoxin-1 B chain but fail to protect against the holotoxin.
Gordon J; Challa A; Levens JM; Gregory CD; Williams JM; Armitage RJ; Cook JP; Roberts LM; Lord JM
Cell Death Differ; 2000 Sep; 7(9):785-94. PubMed ID: 11042673
[TBL] [Abstract][Full Text] [Related]
2. MHC class II proteins contain a potential binding site for the verotoxin receptor glycolipid CD77.
George T; Boyd B; Price M; Lingwood C; Maloney M
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1179-85. PubMed ID: 11838965
[TBL] [Abstract][Full Text] [Related]
3. Temporal ordering of caspase activation and substrate cleavage during antigen receptor-triggered apoptosis in Ramos-Burkitt lymphoma B cells.
An S; Park IC; Rhee CH; Hong SI; Knox K
Int J Oncol; 2003 Aug; 23(2):257-68. PubMed ID: 12851674
[TBL] [Abstract][Full Text] [Related]
4. Apoptosis induced in Burkitt's lymphoma cells via Gb3/CD77, a glycolipid antigen.
Mangeney M; Lingwood CA; Taga S; Caillou B; Tursz T; Wiels J
Cancer Res; 1993 Nov; 53(21):5314-9. PubMed ID: 8221667
[TBL] [Abstract][Full Text] [Related]
5. Comparison of adhesion mechanisms and surface protein expression in CD77-positive and CD77-negative Burkitt's lymphoma cells.
Jackson T; Van Exel C; Reagans K; Verret R; Maloney M
Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1195-200. PubMed ID: 11838967
[TBL] [Abstract][Full Text] [Related]
6. Repression of apoptosis in human B-lymphoma cells by CD40-ligand and Bcl-2: relationship to the cell-cycle and role of the retinoblastoma protein.
Wang H; Grand RJ; Milner AE; Armitage RJ; Gordon J; Gregory CD
Oncogene; 1996 Jul; 13(2):373-9. PubMed ID: 8710376
[TBL] [Abstract][Full Text] [Related]
7. Development of rituximab-resistant lymphoma clones with altered cell signaling and cross-resistance to chemotherapy.
Jazirehi AR; Vega MI; Bonavida B
Cancer Res; 2007 Feb; 67(3):1270-81. PubMed ID: 17283164
[TBL] [Abstract][Full Text] [Related]
8. CD19 has a potential CD77 (globotriaosyl ceramide)-binding site with sequence similarity to verotoxin B-subunits: implications of molecular mimicry for B cell adhesion and enterohemorrhagic Escherichia coli pathogenesis.
Maloney MD; Lingwood CA
J Exp Med; 1994 Jul; 180(1):191-201. PubMed ID: 7516406
[TBL] [Abstract][Full Text] [Related]
9. CD77-dependent retrograde transport of CD19 to the nuclear membrane: functional relationship between CD77 and CD19 during germinal center B-cell apoptosis.
Khine AA; Firtel M; Lingwood CA
J Cell Physiol; 1998 Aug; 176(2):281-92. PubMed ID: 9648915
[TBL] [Abstract][Full Text] [Related]
10. Dynamic interplay between the neutral glycosphingolipid CD77/Gb3 and the therapeutic antibody target CD20 within the lipid bilayer of model B lymphoma cells.
Jarvis RM; Chamba A; Holder MJ; Challa A; Smith DC; Hodgkin MN; Lord JM; Gordon J
Biochem Biophys Res Commun; 2007 Apr; 355(4):944-9. PubMed ID: 17336267
[TBL] [Abstract][Full Text] [Related]
11. Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis.
Liu YJ; Mason DY; Johnson GD; Abbot S; Gregory CD; Hardie DL; Gordon J; MacLennan IC
Eur J Immunol; 1991 Aug; 21(8):1905-10. PubMed ID: 1868875
[TBL] [Abstract][Full Text] [Related]
12. Rituximab (chimeric anti-CD20 monoclonal antibody) inhibits the constitutive nuclear factor-{kappa}B signaling pathway in non-Hodgkin's lymphoma B-cell lines: role in sensitization to chemotherapeutic drug-induced apoptosis.
Jazirehi AR; Huerta-Yepez S; Cheng G; Bonavida B
Cancer Res; 2005 Jan; 65(1):264-76. PubMed ID: 15665303
[TBL] [Abstract][Full Text] [Related]
13. Regulatory roles of N-glycosylation of immunoglobulin M in CD40-CD40L-mediated cell survival of human diffuse large B cell lymphoma.
Suzuki O; Nozawa Y; Abe M
Oncol Rep; 2004 May; 11(5):1031-9. PubMed ID: 15069543
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the Raf-MEK1/2-ERK1/2 signaling pathway, Bcl-xL down-regulation, and chemosensitization of non-Hodgkin's lymphoma B cells by Rituximab.
Jazirehi AR; Vega MI; Chatterjee D; Goodglick L; Bonavida B
Cancer Res; 2004 Oct; 64(19):7117-26. PubMed ID: 15466208
[TBL] [Abstract][Full Text] [Related]
15. Suppression of apoptosis in normal and neoplastic human B lymphocytes by CD40 ligand is independent of Bc1-2 induction.
Holder MJ; Wang H; Milner AE; Casamayor M; Armitage R; Spriggs MK; Fanslow WC; MacLennan IC; Gregory CD; Gordon J
Eur J Immunol; 1993 Sep; 23(9):2368-71. PubMed ID: 8103750
[TBL] [Abstract][Full Text] [Related]
16. Caspase-8-mediated cleavage of Bid and protein phosphatase 2A-mediated activation of Bax are necessary for Verotoxin-1-induced apoptosis in Burkitt's lymphoma cells.
Garibal J; Hollville E; Renouf B; Tétaud C; Wiels J
Cell Signal; 2010 Mar; 22(3):467-75. PubMed ID: 19895884
[TBL] [Abstract][Full Text] [Related]
17. Anti-CD20- and B-cell receptor-mediated apoptosis: evidence for shared intracellular signaling pathways.
Mathas S; Rickers A; Bommert K; Dörken B; Mapara MY
Cancer Res; 2000 Dec; 60(24):7170-6. PubMed ID: 11156427
[TBL] [Abstract][Full Text] [Related]
18. Distinct promoters mediate constitutive and inducible Bcl-XL expression in malignant lymphocytes.
Habens F; Lapham AS; Dallman CL; Pickering BM; Michels J; Marcusson EG; Johnson PW; Packham G
Oncogene; 2007 Mar; 26(13):1910-9. PubMed ID: 16983335
[TBL] [Abstract][Full Text] [Related]
19. The proapoptotic benzodiazepine Bz-423 affects the growth and survival of malignant B cells.
Boitano A; Ellman JA; Glick GD; Opipari AW
Cancer Res; 2003 Oct; 63(20):6870-6. PubMed ID: 14583485
[TBL] [Abstract][Full Text] [Related]
20. Involvement of cell cycle progression in survival signaling through CD40 in the B-lymphocyte line WEHI-231.
Hirai H; Adachi T; Tsubata T
Cell Death Differ; 2004 Mar; 11(3):261-9. PubMed ID: 14647241
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
